Correlation between inhibited alternative complement activity and the protective effect induced by Nocardia lysozyme digest (NLD) during Klebsiella pneumoniae infection in mice

International Journal of Immunopharmacology

Volumn 18, Issue 8-9, 1996, Pages 515-519

  Ivanovska, Nina ^a   Georgieva, Pepa ^a   Barot Ciorbaru, Rita ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b CNRS   (France)

Author keywords

Klebsiella infection; Mouse AP; NLD

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOMODULATING AGENT; NOCARDIA LYSOZYME EXTRACT; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG ADMINISTRATION; HOST RESISTANCE; IMMUNE DEFICIENCY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NOCARDIA; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL PROTEINS; CELL EXTRACTS; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, ALTERNATIVE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; MICE, INBRED ICR; MURAMIDASE; NOCARDIA;

EID: 0030207763     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(96)00048-3     Document Type: Article

References (22)

1. Alberti, S., Marques, G., Camprubi, S., Merino, S., Tomas, J. M., Vivanco, F. & Benedi, V. (1993) C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun., 61, 852-860.
2. Alper, C. A., Abramson, N., Sohnston, R. B., Jandl, J. H. & Rosen, F. S. (1970) Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of third component of complement (C3). N. Engl. J. Med., 282, 349-354.
3. Balow, J. E., Hurley, D. L. & Fanci, A. S. (1975) Cyclophosphamide suppression of established cell-mediated immunity. J. clin. Invest., 56, 67-70.
4. Barot-Ciorbaru, R. (1994) Immunomodulation by bacterial fractions. Int. J. Immunopharmac., 16, 469-473.
5. Birdsey, V., Lindorfer, J. & Gewurz, H. (1971) Interactions of toxic venoms with the complement system. Immunology, 21, 299-310.
6. Clas, F., Shmids, G. & Loos, M. (1985). The role of classical pathway of the bactericidal effect of normal sera against gram-negative bacteria. In Current Topics in Microbiology and Immunology (ed. Loos, M.), pp. 19-73. Springer-Verlag, Berlin.
7. Cochrane, C. G., Müller-Eberhard, H. J. & Aikin, B. S. (1970) Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immun., 105, 55-69.
8. Figueroa, J. E. & Densen, P. (1991) Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev., 4, 359-395.
9. Foresta, P., Riccardi, C. & Martelly, A. M. (1992) Immunorestorative properties of ST 789 on experimentally immunosuppressed and infected mice. Thymus, 19(Suppl. 1), S97-S107.
10. Ivanovska, N., Neychev, H., Georgieva, P., Barot-Ciorbaru, R. (1995). Modulation of complement activity by Nocardia lysozyme digest (NLD). Int. J. Immunopathol. Pharmac., in press.
11. Joiner, K. A., Brown, E. J. & Frank, M. M. (1984) Complement and bacteria: chemistry and biology in host defense. A. Rev. Immun., 2, 461-491.
12. Jungi, T. W. & Pepys, M. B. (1981) Delayed hypersensitivity reactions to Listeria monocytoegenes in rats decomplemented with cobra venom factor and in C5-deficient mice. Immunology, 43, 271-279.
13. Klerx, J. P. M., Beukelman, C. J., van Dijk, H. & Willers, J. M. N. (1983) Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J. Immun. Methods, 63, 215-220.
14. Klerx, J. P. M., Beukelman, C. J., van Dijk, H., van Overveld, W. J., van der Maaden, W. J. & Willers, J. M. N. (1985) Increased local complement levels upon intraperitoneal injection of mice with Listeria monocytogenes and regulation by polyanions. Infect. Immun., 49, 841-843.
15. McConnel, I. & Hopkins, J. (1981) Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown. Immunology, 42, 217-223.
16. Meuth, J. L., Morgan, E. L., Discipio, R. G. & Hugli, T. E. (1983) Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferation responses by kallikrein cleavage of human iC3b. J. Immun., 130, 2605-2611.
17. Morgan, E. L., Weigle, W. O. & Hugli, T. E. (1982) Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune response. J. exp. Med., 155, 1412-1426.
18. Parant, M. (1994) Influence of synthetic adjuvants on nonspecific resistance to infections. Int. J. Immunopharmac., 16, 445-449.
19. Pepys, M. B. (1972) Role of complement in induction of allergic response. Nature New Biol., 237, 157-159.
20. Pepys, M. B. (1974) Role of complement in induction of antibody production in vivo. Effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. exp. Med., 140, 126-145.
21. Pick, E. & Keisari, Y. (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J. Immun. Meth., 38, 161-170.
22. Pierson, C. C., Johnson, A. G. & Feller, I. (1976) Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice. Infect. Immun., 14, 168-177.